Treatment of Heart Failure with Reduced Ejection Fraction: Current Update / 대한내과학회지
Korean Journal of Medicine
;
: 127-134, 2015.
Artículo
en Coreano
| WPRIM
| ID: wpr-201034
ABSTRACT
The prevalence of heart failure (HF) has been steadily increasing and it now creates an enormous social and economic burden. HF is a syndrome characterized by a high mortality rate, frequent hospitalization, a reduced quality of life, and a complex therapeutic regimen. In the last three decades, major progress in both the diagnosis and management of HF has taken place, and the pharmacologic and non-pharmacologic advances have led to a significant improvement in survival and symptoms in HF patients. After an accurate diagnosis, a proper HF management plan requires a multi-level team approach comprised of the correct combination of drug therapy, device therapy, and surgery, including heart transplantation. In this review, we focused on the pharmacologic and non-pharmacologic treatment strategies for HF with reduced ejection fraction. The goal was to develop treatment guidelines based on significant evidence derived from large clinical trials.
Texto completo:
Disponible
Índice:
WPRIM (Pacífico Occidental)
Asunto principal:
Calidad de Vida
/
Prevalencia
/
Mortalidad
/
Trasplante de Corazón
/
Diagnóstico
/
Quimioterapia
/
Insuficiencia Cardíaca Sistólica
/
Insuficiencia Cardíaca
/
Hospitalización
Tipo de estudio:
Estudio diagnóstico
/
Guía de Práctica Clínica
/
Estudio de prevalencia
/
Estudio pronóstico
Límite:
Humanos
Idioma:
Coreano
Revista:
Korean Journal of Medicine
Año:
2015
Tipo del documento:
Artículo
Similares
MEDLINE
...
LILACS
LIS